Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana M Chahine

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Continuum (Minneapolis, Minn.)|October 12, 2022
Prodromal α-SynucleinopathiesLana M Chahine
Journal of Parkinson'S Disease|April 9, 2019
Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter ImagingJason Massa, Lana M Chahine
Handbook of Clinical Neurology|February 21, 2023
Role of novel endpoints and evaluations of response in Parkinson diseaseLana M Chahine, Tanya Simuni
Movement Disorders Clinical Practice|October 27, 2018
Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Lana M Chahine, Matthew B Stern
Neurology|June 25, 2026
Brain-Aggregated and Body-Aggregated Alpha-Synuclein in Lewy Body Disease: Sowing Initial Seeds of UnderstandingDavid G Coughlin, Lana M Chahine
Neurobiology of Disease|September 5, 2020
Sleep and circadian rhythms in the treatment, trajectory, and prevention of neurodegenerative diseaseKristine A Wilckens, Lana M Chahine
Neurology|May 17, 2023
Physical Activity and the Risk of Parkinson Disease: Moving in the Right DirectionLana M Chahine, Sirwan K L Darweesh
Current Treatment Options in Neurology|June 2, 2017
Treatment of Sleep Dysfunction in Parkinson's DiseaseAmy W Amara, Lana M Chahine, Aleksandar Videnovic
Movement Disorders Clinical Practice|August 11, 2020
Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseCameron Miller-Patterson, Kyle A Edwards, Lana M Chahine
Neuro-Degenerative Diseases|July 5, 2022
Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic TherapyCameron Miller-Patterson, Jesse Y Hsu, Lana M Chahine
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Continuum (Minneapolis, Minn.)|October 12, 2022
Prodromal α-SynucleinopathiesLana M Chahine
Journal of Parkinson'S Disease|April 9, 2019
Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter ImagingJason Massa, Lana M Chahine
Handbook of Clinical Neurology|February 21, 2023
Role of novel endpoints and evaluations of response in Parkinson diseaseLana M Chahine, Tanya Simuni
Movement Disorders Clinical Practice|October 27, 2018
Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Lana M Chahine, Matthew B Stern
Neurology|June 25, 2026
Brain-Aggregated and Body-Aggregated Alpha-Synuclein in Lewy Body Disease: Sowing Initial Seeds of UnderstandingDavid G Coughlin, Lana M Chahine
Neurobiology of Disease|September 5, 2020
Sleep and circadian rhythms in the treatment, trajectory, and prevention of neurodegenerative diseaseKristine A Wilckens, Lana M Chahine
Neurology|May 17, 2023
Physical Activity and the Risk of Parkinson Disease: Moving in the Right DirectionLana M Chahine, Sirwan K L Darweesh
Current Treatment Options in Neurology|June 2, 2017
Treatment of Sleep Dysfunction in Parkinson's DiseaseAmy W Amara, Lana M Chahine, Aleksandar Videnovic
Movement Disorders Clinical Practice|August 11, 2020
Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseCameron Miller-Patterson, Kyle A Edwards, Lana M Chahine
Neuro-Degenerative Diseases|July 5, 2022
Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic TherapyCameron Miller-Patterson, Jesse Y Hsu, Lana M Chahine
Pageof 12